News

New Jersey based PTC has announced the receipt of two government grants to support clinical development programs in rare disorders. The US Department of Defense Neurofibromatosis Research Program

Israel based Pluristem has announced that the Paul Ehrlich Institute (PEI), the German competent authority in the EU, has approved the Clinical Trial Application (CTA). EU has granted

Autonomy has announced that the Greater Cincinnati Behavioral Health Services (GCB) has selected its information processing solutions to securely capture, route, store and manage its patients records. GCB’

Noteworthy Medical Systems has launched NetPay, a web-based application that integrates with NetPracticePM, to enable physicians collect all patient payments at the point of service when patients are

URAC and CARF International have launched a new tool for case management professionals. The uSPEQ/URAC Participant Experience Survey for Case Management (uSPEQ-CM), will help evaluate and improve the

The Society of Chemical Manufacturers and Affiliates (SOCMA) has announced the approval of five new companies for membership. The announcement was made on June 2 meeting of the

Genzyme has announced that the European Commission has approved Renvela (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease (CKD). Renvela is a

New Jersey based Orphan and Ikaria, have announced that the FDA has accepted the final section of the New Drug Application (NDA) filing seeking marketing approval for Lucassin

Misonix has announced today that it has purchased three patents associated with High Intensity Focused Ultrasound (HIFU) technology from ProRhythm. The patents relate to HIFU transducer arrays method